This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abraham, E. J. Articles by Frawley, L. S. Search for Related Content PubMed PubMed Citation Articles by Abraham, E. J. Articles by Frawley, L. S.

Transforming Growth Factor ß1 Is a Paracrine Inhibitor of Prolactin Gene Expression¹

Laboratory of Molecular Dynamics, Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, South Carolina 29425

Address all correspondence and requests for reprints to: Dr. L. Stephen Frawley, Laboratory of Molecular Dynamics, Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston, South Carolina 29425. E-mail: frawleys{at}musc.edu

We have shown previously that rat mammotropes produce an activity that suppresses PRL gene expression by neighboring mammotropes. Here, we tested the hypothesis that this mammotrope-derived inhibitor is transforming growth factor-ß1 (TGFß1). To this end, we pursued a two-pronged strategy wherein we added exogenous TGFß1 to primary cultures of anterior pituitary cells transfected with a rat PRL-luc construct. Measurement of luciferase activity by luminometry of extracts revealed that administration of TGFß1, over a range of doses shown by others to be secreted by cultures of pituitary cells, caused a significant (P < 0.05) suppression of PRL gene expression. In contrast, immunoremoval of secreted TGFß1 led to an elevation of PRL promoter-driven reporter activity in these cultures. In a subsequent study, we repeated these experiments with a single cell model in an attempt to determine the demographics of the cellular responses. Accordingly, we transfected (via microinjection) individual mammotropes with the rat PRL-luc construct; exposed them to TGFß1, its neutralizing antibody, or respective controls; and then assessed PRL gene expression in "real-time" by quantification of photons emitted by the living cells after exposure to the substrate luciferin. Our results revealed that 1) TGFß1 inhibited PRL gene expression in all mammotrope studied; 2) only a subgroup of mammotropes (23%) was relieved of TGFß1 inhibition by antibody treatment; and 3) the growth factor exerted its inhibitory effect via a paracrine, as opposed to an autocrine, mechanism. These findings identify TGFß1 as the paracrine agent that exerts a tonic inhibitory influence over PRL gene expression in mammotropes.

This article has been cited by other articles:

				U. Renner, P. Lohrer, L. Schaaf, M. Feirer, K. Schmitt, C. Onofri, E. Arzt, and G. K. Stalla Transforming Growth Factor-{beta} Stimulates Vascular Endothelial Growth Factor Production by Folliculostellate Pituitary Cells Endocrinology, October 1, 2002; 143(10): 3759 - 3765. [Abstract] [Full Text] [PDF]

				L. M. Bilezikjian, A. Z. Corrigan, A. L. Blount, Y. Chen, and W. W. Vale Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-{{beta}} Signaling in Anterior Pituitary Cells Endocrinology, March 1, 2001; 142(3): 1065 - 1072. [Abstract] [Full Text] [PDF]

				J. Schwartz Intercellular Communication in the Anterior Pituitary Endocr. Rev., October 1, 2000; 21(5): 488 - 513. [Abstract] [Full Text]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]